nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—Tolvaptan—Zafirlukast—asthma	0.506	1	CrCrCtD
Conivaptan—CYP3A4—Fluticasone furoate—asthma	0.0219	0.0796	CbGbCtD
Conivaptan—CYP3A4—Budesonide—asthma	0.0195	0.0709	CbGbCtD
Conivaptan—CYP3A4—Indacaterol—asthma	0.0179	0.0649	CbGbCtD
Conivaptan—CYP3A4—Ciclesonide—asthma	0.0179	0.0649	CbGbCtD
Conivaptan—CYP3A4—Salmeterol—asthma	0.0166	0.0603	CbGbCtD
Conivaptan—CYP3A4—Flunisolide—asthma	0.0166	0.0603	CbGbCtD
Conivaptan—CYP3A4—Salbutamol—asthma	0.0166	0.0603	CbGbCtD
Conivaptan—CYP3A4—Ipratropium bromide—asthma	0.0148	0.0538	CbGbCtD
Conivaptan—CYP3A4—Zileuton—asthma	0.0148	0.0538	CbGbCtD
Conivaptan—CYP3A4—Fluticasone Propionate—asthma	0.0141	0.0513	CbGbCtD
Conivaptan—CYP3A4—Zafirlukast—asthma	0.013	0.0473	CbGbCtD
Conivaptan—CYP3A4—Tiotropium—asthma	0.0112	0.0407	CbGbCtD
Conivaptan—CYP3A4—Aminophylline—asthma	0.0107	0.0389	CbGbCtD
Conivaptan—CYP3A4—Theophylline—asthma	0.0101	0.0365	CbGbCtD
Conivaptan—CYP3A4—Loratadine—asthma	0.00954	0.0346	CbGbCtD
Conivaptan—CYP3A4—Montelukast—asthma	0.00954	0.0346	CbGbCtD
Conivaptan—CYP3A4—Methylprednisolone—asthma	0.00873	0.0317	CbGbCtD
Conivaptan—CYP3A4—Triamcinolone—asthma	0.00661	0.024	CbGbCtD
Conivaptan—CYP3A4—Betamethasone—asthma	0.00568	0.0206	CbGbCtD
Conivaptan—CYP3A4—Prednisolone—asthma	0.0056	0.0203	CbGbCtD
Conivaptan—CYP3A4—Hydrocortisone—asthma	0.00531	0.0193	CbGbCtD
Conivaptan—CYP3A4—Prednisone—asthma	0.00529	0.0192	CbGbCtD
Conivaptan—CYP3A4—Dexamethasone—asthma	0.0033	0.012	CbGbCtD
Conivaptan—AVPR1A—respiratory system—asthma	0.00317	0.294	CbGeAlD
Conivaptan—AVPR2—respiratory system—asthma	0.00263	0.243	CbGeAlD
Conivaptan—AVPR1A—adrenal gland—asthma	0.00192	0.178	CbGeAlD
Conivaptan—AVPR1A—lung—asthma	0.00168	0.156	CbGeAlD
Conivaptan—AVPR2—lung—asthma	0.0014	0.129	CbGeAlD
Conivaptan—Dry mouth—Formoterol—asthma	0.000127	0.0011	CcSEcCtD
Conivaptan—Dry mouth—Arformoterol—asthma	0.000127	0.0011	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Montelukast—asthma	0.000126	0.00109	CcSEcCtD
Conivaptan—Pruritus—Ipratropium bromide—asthma	0.000126	0.00109	CcSEcCtD
Conivaptan—Hypertension—Salbutamol—asthma	0.000124	0.00107	CcSEcCtD
Conivaptan—Infection—Formoterol—asthma	0.000123	0.00107	CcSEcCtD
Conivaptan—Infection—Arformoterol—asthma	0.000123	0.00107	CcSEcCtD
Conivaptan—Headache—Cromoglicic acid—asthma	0.000122	0.00105	CcSEcCtD
Conivaptan—Pain—Flunisolide—asthma	0.000122	0.00105	CcSEcCtD
Conivaptan—Constipation—Flunisolide—asthma	0.000122	0.00105	CcSEcCtD
Conivaptan—Body temperature increased—Loratadine—asthma	0.000122	0.00105	CcSEcCtD
Conivaptan—Pruritus—Fluticasone Propionate—asthma	0.000122	0.00105	CcSEcCtD
Conivaptan—Nervous system disorder—Formoterol—asthma	0.000122	0.00105	CcSEcCtD
Conivaptan—Nervous system disorder—Arformoterol—asthma	0.000122	0.00105	CcSEcCtD
Conivaptan—Diarrhoea—Ipratropium bromide—asthma	0.000122	0.00105	CcSEcCtD
Conivaptan—Hypokalaemia—Hydrocortisone—asthma	0.000121	0.00105	CcSEcCtD
Conivaptan—Infection—Montelukast—asthma	0.000121	0.00104	CcSEcCtD
Conivaptan—Skin disorder—Formoterol—asthma	0.00012	0.00104	CcSEcCtD
Conivaptan—Skin disorder—Arformoterol—asthma	0.00012	0.00104	CcSEcCtD
Conivaptan—Hypertension—Budesonide—asthma	0.00012	0.00104	CcSEcCtD
Conivaptan—Dry mouth—Salbutamol—asthma	0.00012	0.00103	CcSEcCtD
Conivaptan—Nervous system disorder—Montelukast—asthma	0.000119	0.00103	CcSEcCtD
Conivaptan—Sepsis—Prednisone—asthma	0.000119	0.00103	CcSEcCtD
Conivaptan—Skin disorder—Montelukast—asthma	0.000118	0.00102	CcSEcCtD
Conivaptan—Diarrhoea—Fluticasone Propionate—asthma	0.000118	0.00102	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Budesonide—asthma	0.000118	0.00102	CcSEcCtD
Conivaptan—Diarrhoea—Salmeterol—asthma	0.000117	0.00102	CcSEcCtD
Conivaptan—Feeling abnormal—Flunisolide—asthma	0.000117	0.00102	CcSEcCtD
Conivaptan—Cardiac failure—Dexamethasone—asthma	0.000117	0.00101	CcSEcCtD
Conivaptan—Cardiac failure—Betamethasone—asthma	0.000117	0.00101	CcSEcCtD
Conivaptan—Infection—Salbutamol—asthma	0.000116	0.00101	CcSEcCtD
Conivaptan—Hypotension—Arformoterol—asthma	0.000116	0.001	CcSEcCtD
Conivaptan—Hypotension—Formoterol—asthma	0.000116	0.001	CcSEcCtD
Conivaptan—Dry mouth—Budesonide—asthma	0.000116	0.001	CcSEcCtD
Conivaptan—Nausea—Cromoglicic acid—asthma	0.000116	0.001	CcSEcCtD
Conivaptan—Pruritus—Aminophylline—asthma	0.000115	0.000998	CcSEcCtD
Conivaptan—Nervous system disorder—Salbutamol—asthma	0.000115	0.000994	CcSEcCtD
Conivaptan—Confusional state—Budesonide—asthma	0.000114	0.00099	CcSEcCtD
Conivaptan—Skin disorder—Salbutamol—asthma	0.000114	0.000984	CcSEcCtD
Conivaptan—Vomiting—Ipratropium bromide—asthma	0.000113	0.000978	CcSEcCtD
Conivaptan—Pain—Mometasone—asthma	0.000113	0.000978	CcSEcCtD
Conivaptan—Infection—Budesonide—asthma	0.000113	0.000975	CcSEcCtD
Conivaptan—Body temperature increased—Flunisolide—asthma	0.000113	0.000974	CcSEcCtD
Conivaptan—Insomnia—Arformoterol—asthma	0.000112	0.000971	CcSEcCtD
Conivaptan—Insomnia—Formoterol—asthma	0.000112	0.000971	CcSEcCtD
Conivaptan—Diarrhoea—Aminophylline—asthma	0.000112	0.000965	CcSEcCtD
Conivaptan—Headache—Ipratropium bromide—asthma	0.000111	0.000963	CcSEcCtD
Conivaptan—Nervous system disorder—Budesonide—asthma	0.000111	0.000963	CcSEcCtD
Conivaptan—Skin disorder—Budesonide—asthma	0.00011	0.000954	CcSEcCtD
Conivaptan—Insomnia—Montelukast—asthma	0.00011	0.000951	CcSEcCtD
Conivaptan—Hypotension—Salbutamol—asthma	0.000109	0.000947	CcSEcCtD
Conivaptan—Vomiting—Fluticasone Propionate—asthma	0.000109	0.000946	CcSEcCtD
Conivaptan—Vomiting—Salmeterol—asthma	0.000109	0.000944	CcSEcCtD
Conivaptan—Pruritus—Tiotropium—asthma	0.000109	0.000941	CcSEcCtD
Conivaptan—Headache—Fluticasone Propionate—asthma	0.000108	0.000933	CcSEcCtD
Conivaptan—Headache—Salmeterol—asthma	0.000108	0.00093	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Formoterol—asthma	0.000107	0.000927	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Arformoterol—asthma	0.000107	0.000927	CcSEcCtD
Conivaptan—Pain—Arformoterol—asthma	0.000106	0.000918	CcSEcCtD
Conivaptan—Pain—Formoterol—asthma	0.000106	0.000918	CcSEcCtD
Conivaptan—Constipation—Formoterol—asthma	0.000106	0.000918	CcSEcCtD
Conivaptan—Constipation—Arformoterol—asthma	0.000106	0.000918	CcSEcCtD
Conivaptan—Insomnia—Salbutamol—asthma	0.000106	0.000917	CcSEcCtD
Conivaptan—Nausea—Ipratropium bromide—asthma	0.000106	0.000914	CcSEcCtD
Conivaptan—Diarrhoea—Loratadine—asthma	0.000105	0.000912	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Montelukast—asthma	0.000105	0.000908	CcSEcCtD
Conivaptan—Body temperature increased—Mometasone—asthma	0.000104	0.000904	CcSEcCtD
Conivaptan—Pain—Montelukast—asthma	0.000104	0.000899	CcSEcCtD
Conivaptan—Hypokalaemia—Dexamethasone—asthma	0.000104	0.000898	CcSEcCtD
Conivaptan—Hypokalaemia—Betamethasone—asthma	0.000104	0.000898	CcSEcCtD
Conivaptan—Vomiting—Aminophylline—asthma	0.000104	0.000897	CcSEcCtD
Conivaptan—Infestation NOS—Hydrocortisone—asthma	0.000103	0.00089	CcSEcCtD
Conivaptan—Infestation—Hydrocortisone—asthma	0.000103	0.00089	CcSEcCtD
Conivaptan—Insomnia—Budesonide—asthma	0.000103	0.000888	CcSEcCtD
Conivaptan—Feeling abnormal—Arformoterol—asthma	0.000102	0.000884	CcSEcCtD
Conivaptan—Feeling abnormal—Formoterol—asthma	0.000102	0.000884	CcSEcCtD
Conivaptan—Nausea—Fluticasone Propionate—asthma	0.000102	0.000884	CcSEcCtD
Conivaptan—Headache—Aminophylline—asthma	0.000102	0.000883	CcSEcCtD
Conivaptan—Nausea—Salmeterol—asthma	0.000102	0.000882	CcSEcCtD
Conivaptan—Cardiac failure—Prednisone—asthma	0.000102	0.000881	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Salbutamol—asthma	0.000101	0.000875	CcSEcCtD
Conivaptan—Pruritus—Flunisolide—asthma	0.000101	0.000872	CcSEcCtD
Conivaptan—Pain—Salbutamol—asthma	0.0001	0.000867	CcSEcCtD
Conivaptan—Constipation—Salbutamol—asthma	0.0001	0.000867	CcSEcCtD
Conivaptan—Body temperature increased—Formoterol—asthma	9.81e-05	0.000848	CcSEcCtD
Conivaptan—Body temperature increased—Arformoterol—asthma	9.81e-05	0.000848	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Budesonide—asthma	9.8e-05	0.000848	CcSEcCtD
Conivaptan—Vomiting—Loratadine—asthma	9.79e-05	0.000847	CcSEcCtD
Conivaptan—Vomiting—Tiotropium—asthma	9.77e-05	0.000846	CcSEcCtD
Conivaptan—Diarrhoea—Flunisolide—asthma	9.75e-05	0.000843	CcSEcCtD
Conivaptan—Pain—Budesonide—asthma	9.7e-05	0.000839	CcSEcCtD
Conivaptan—Constipation—Budesonide—asthma	9.7e-05	0.000839	CcSEcCtD
Conivaptan—Nausea—Aminophylline—asthma	9.68e-05	0.000838	CcSEcCtD
Conivaptan—Infestation NOS—Methylprednisolone—asthma	9.67e-05	0.000836	CcSEcCtD
Conivaptan—Infestation—Methylprednisolone—asthma	9.67e-05	0.000836	CcSEcCtD
Conivaptan—Feeling abnormal—Salbutamol—asthma	9.65e-05	0.000835	CcSEcCtD
Conivaptan—Headache—Loratadine—asthma	9.65e-05	0.000835	CcSEcCtD
Conivaptan—Headache—Tiotropium—asthma	9.63e-05	0.000833	CcSEcCtD
Conivaptan—Body temperature increased—Montelukast—asthma	9.61e-05	0.000831	CcSEcCtD
Conivaptan—Pruritus—Mometasone—asthma	9.35e-05	0.000809	CcSEcCtD
Conivaptan—Feeling abnormal—Budesonide—asthma	9.35e-05	0.000809	CcSEcCtD
Conivaptan—Body temperature increased—Salbutamol—asthma	9.26e-05	0.000801	CcSEcCtD
Conivaptan—Nausea—Loratadine—asthma	9.15e-05	0.000791	CcSEcCtD
Conivaptan—Nausea—Tiotropium—asthma	9.13e-05	0.00079	CcSEcCtD
Conivaptan—Vomiting—Flunisolide—asthma	9.06e-05	0.000784	CcSEcCtD
Conivaptan—Diarrhoea—Mometasone—asthma	9.04e-05	0.000782	CcSEcCtD
Conivaptan—Hypokalaemia—Prednisone—asthma	9.04e-05	0.000782	CcSEcCtD
Conivaptan—Body temperature increased—Budesonide—asthma	8.97e-05	0.000776	CcSEcCtD
Conivaptan—Headache—Flunisolide—asthma	8.93e-05	0.000772	CcSEcCtD
Conivaptan—Hyperglycaemia—Betamethasone—asthma	8.89e-05	0.000769	CcSEcCtD
Conivaptan—Hyperglycaemia—Dexamethasone—asthma	8.89e-05	0.000769	CcSEcCtD
Conivaptan—Pruritus—Formoterol—asthma	8.78e-05	0.000759	CcSEcCtD
Conivaptan—Pruritus—Arformoterol—asthma	8.78e-05	0.000759	CcSEcCtD
Conivaptan—Pruritus—Montelukast—asthma	8.6e-05	0.000744	CcSEcCtD
Conivaptan—Diarrhoea—Formoterol—asthma	8.49e-05	0.000734	CcSEcCtD
Conivaptan—Diarrhoea—Arformoterol—asthma	8.49e-05	0.000734	CcSEcCtD
Conivaptan—Nausea—Flunisolide—asthma	8.46e-05	0.000732	CcSEcCtD
Conivaptan—Vomiting—Mometasone—asthma	8.4e-05	0.000727	CcSEcCtD
Conivaptan—Diarrhoea—Montelukast—asthma	8.31e-05	0.000719	CcSEcCtD
Conivaptan—Pruritus—Salbutamol—asthma	8.29e-05	0.000717	CcSEcCtD
Conivaptan—Headache—Mometasone—asthma	8.28e-05	0.000716	CcSEcCtD
Conivaptan—Erythema—Prednisolone—asthma	8.23e-05	0.000712	CcSEcCtD
Conivaptan—Mental disorder—Hydrocortisone—asthma	8.09e-05	0.0007	CcSEcCtD
Conivaptan—Cardiac disorder—Methylprednisolone—asthma	8.05e-05	0.000697	CcSEcCtD
Conivaptan—Malnutrition—Hydrocortisone—asthma	8.04e-05	0.000696	CcSEcCtD
Conivaptan—Erythema—Hydrocortisone—asthma	8.04e-05	0.000696	CcSEcCtD
Conivaptan—Pruritus—Budesonide—asthma	8.03e-05	0.000695	CcSEcCtD
Conivaptan—Diarrhoea—Salbutamol—asthma	8.01e-05	0.000693	CcSEcCtD
Conivaptan—Vomiting—Formoterol—asthma	7.89e-05	0.000682	CcSEcCtD
Conivaptan—Vomiting—Arformoterol—asthma	7.89e-05	0.000682	CcSEcCtD
Conivaptan—Angiopathy—Methylprednisolone—asthma	7.87e-05	0.000681	CcSEcCtD
Conivaptan—Nausea—Mometasone—asthma	7.85e-05	0.000679	CcSEcCtD
Conivaptan—Mediastinal disorder—Methylprednisolone—asthma	7.82e-05	0.000677	CcSEcCtD
Conivaptan—Headache—Formoterol—asthma	7.77e-05	0.000672	CcSEcCtD
Conivaptan—Headache—Arformoterol—asthma	7.77e-05	0.000672	CcSEcCtD
Conivaptan—Diarrhoea—Budesonide—asthma	7.76e-05	0.000672	CcSEcCtD
Conivaptan—Hyperglycaemia—Prednisone—asthma	7.74e-05	0.00067	CcSEcCtD
Conivaptan—Vomiting—Montelukast—asthma	7.73e-05	0.000668	CcSEcCtD
Conivaptan—Headache—Montelukast—asthma	7.61e-05	0.000659	CcSEcCtD
Conivaptan—Mental disorder—Methylprednisolone—asthma	7.6e-05	0.000658	CcSEcCtD
Conivaptan—Erythema—Triamcinolone—asthma	7.57e-05	0.000655	CcSEcCtD
Conivaptan—Erythema—Methylprednisolone—asthma	7.55e-05	0.000654	CcSEcCtD
Conivaptan—Malnutrition—Methylprednisolone—asthma	7.55e-05	0.000654	CcSEcCtD
Conivaptan—Vomiting—Salbutamol—asthma	7.45e-05	0.000644	CcSEcCtD
Conivaptan—Nausea—Formoterol—asthma	7.37e-05	0.000638	CcSEcCtD
Conivaptan—Nausea—Arformoterol—asthma	7.37e-05	0.000638	CcSEcCtD
Conivaptan—Headache—Salbutamol—asthma	7.34e-05	0.000635	CcSEcCtD
Conivaptan—Nausea—Montelukast—asthma	7.22e-05	0.000624	CcSEcCtD
Conivaptan—Vomiting—Budesonide—asthma	7.21e-05	0.000624	CcSEcCtD
Conivaptan—Angiopathy—Betamethasone—asthma	7.16e-05	0.000619	CcSEcCtD
Conivaptan—Angiopathy—Dexamethasone—asthma	7.16e-05	0.000619	CcSEcCtD
Conivaptan—Headache—Budesonide—asthma	7.11e-05	0.000615	CcSEcCtD
Conivaptan—Hypertension—Prednisolone—asthma	7.11e-05	0.000615	CcSEcCtD
Conivaptan—Nausea—Salbutamol—asthma	6.96e-05	0.000602	CcSEcCtD
Conivaptan—Hypertension—Hydrocortisone—asthma	6.94e-05	0.000601	CcSEcCtD
Conivaptan—Erythema—Betamethasone—asthma	6.87e-05	0.000594	CcSEcCtD
Conivaptan—Erythema—Dexamethasone—asthma	6.87e-05	0.000594	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	6.8e-05	0.000588	CcSEcCtD
Conivaptan—Nausea—Budesonide—asthma	6.74e-05	0.000583	CcSEcCtD
Conivaptan—Hypertension—Triamcinolone—asthma	6.54e-05	0.000565	CcSEcCtD
Conivaptan—Hypertension—Methylprednisolone—asthma	6.52e-05	0.000564	CcSEcCtD
Conivaptan—Infection—Hydrocortisone—asthma	6.52e-05	0.000564	CcSEcCtD
Conivaptan—Nervous system disorder—Hydrocortisone—asthma	6.43e-05	0.000557	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	6.39e-05	0.000553	CcSEcCtD
Conivaptan—Skin disorder—Hydrocortisone—asthma	6.37e-05	0.000551	CcSEcCtD
Conivaptan—Dry mouth—Triamcinolone—asthma	6.3e-05	0.000545	CcSEcCtD
Conivaptan—Angiopathy—Prednisone—asthma	6.23e-05	0.000539	CcSEcCtD
Conivaptan—Confusional state—Methylprednisolone—asthma	6.22e-05	0.000538	CcSEcCtD
Conivaptan—Infection—Triamcinolone—asthma	6.14e-05	0.000531	CcSEcCtD
Conivaptan—Hypotension—Hydrocortisone—asthma	6.13e-05	0.00053	CcSEcCtD
Conivaptan—Infection—Methylprednisolone—asthma	6.12e-05	0.00053	CcSEcCtD
Conivaptan—Insomnia—Prednisolone—asthma	6.08e-05	0.000526	CcSEcCtD
Conivaptan—Nervous system disorder—Methylprednisolone—asthma	6.05e-05	0.000523	CcSEcCtD
Conivaptan—Mental disorder—Prednisone—asthma	6.02e-05	0.000521	CcSEcCtD
Conivaptan—Skin disorder—Methylprednisolone—asthma	5.99e-05	0.000518	CcSEcCtD
Conivaptan—Malnutrition—Prednisone—asthma	5.98e-05	0.000518	CcSEcCtD
Conivaptan—Erythema—Prednisone—asthma	5.98e-05	0.000518	CcSEcCtD
Conivaptan—Insomnia—Hydrocortisone—asthma	5.93e-05	0.000513	CcSEcCtD
Conivaptan—Hypertension—Betamethasone—asthma	5.93e-05	0.000513	CcSEcCtD
Conivaptan—Hypertension—Dexamethasone—asthma	5.93e-05	0.000513	CcSEcCtD
Conivaptan—Hypotension—Methylprednisolone—asthma	5.76e-05	0.000498	CcSEcCtD
Conivaptan—Pain—Prednisolone—asthma	5.75e-05	0.000497	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Hydrocortisone—asthma	5.66e-05	0.00049	CcSEcCtD
Conivaptan—Pain—Hydrocortisone—asthma	5.61e-05	0.000485	CcSEcCtD
Conivaptan—Insomnia—Triamcinolone—asthma	5.59e-05	0.000483	CcSEcCtD
Conivaptan—Insomnia—Methylprednisolone—asthma	5.58e-05	0.000482	CcSEcCtD
Conivaptan—Infection—Betamethasone—asthma	5.57e-05	0.000482	CcSEcCtD
Conivaptan—Infection—Dexamethasone—asthma	5.57e-05	0.000482	CcSEcCtD
Conivaptan—Feeling abnormal—Prednisolone—asthma	5.54e-05	0.000479	CcSEcCtD
Conivaptan—Anaemia—Prednisone—asthma	5.53e-05	0.000478	CcSEcCtD
Conivaptan—Nervous system disorder—Betamethasone—asthma	5.5e-05	0.000476	CcSEcCtD
Conivaptan—Nervous system disorder—Dexamethasone—asthma	5.5e-05	0.000476	CcSEcCtD
Conivaptan—Feeling abnormal—Hydrocortisone—asthma	5.41e-05	0.000468	CcSEcCtD
Conivaptan—Pain—Triamcinolone—asthma	5.28e-05	0.000457	CcSEcCtD
Conivaptan—Hypotension—Betamethasone—asthma	5.24e-05	0.000453	CcSEcCtD
Conivaptan—Hypotension—Dexamethasone—asthma	5.24e-05	0.000453	CcSEcCtD
Conivaptan—Body temperature increased—Hydrocortisone—asthma	5.19e-05	0.000449	CcSEcCtD
Conivaptan—Hypertension—Prednisone—asthma	5.16e-05	0.000447	CcSEcCtD
Conivaptan—Feeling abnormal—Triamcinolone—asthma	5.09e-05	0.000441	CcSEcCtD
Conivaptan—Feeling abnormal—Methylprednisolone—asthma	5.08e-05	0.00044	CcSEcCtD
Conivaptan—Insomnia—Betamethasone—asthma	5.07e-05	0.000439	CcSEcCtD
Conivaptan—Insomnia—Dexamethasone—asthma	5.07e-05	0.000439	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	5.06e-05	0.000438	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	4.97e-05	0.00054	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	4.95e-05	0.000537	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—POMC—asthma	4.93e-05	0.000535	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL5—asthma	4.9e-05	0.000532	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—POMC—asthma	4.9e-05	0.000532	CbGpPWpGaD
Conivaptan—Body temperature increased—Triamcinolone—asthma	4.88e-05	0.000423	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—IL5—asthma	4.86e-05	0.000528	CbGpPWpGaD
Conivaptan—Infection—Prednisone—asthma	4.85e-05	0.00042	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Betamethasone—asthma	4.84e-05	0.000419	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Dexamethasone—asthma	4.84e-05	0.000419	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CCL2—asthma	4.83e-05	0.000524	CbGpPWpGaD
Conivaptan—Pain—Dexamethasone—asthma	4.79e-05	0.000415	CcSEcCtD
Conivaptan—Pain—Betamethasone—asthma	4.79e-05	0.000415	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—CCL2—asthma	4.79e-05	0.00052	CbGpPWpGaD
Conivaptan—Nervous system disorder—Prednisone—asthma	4.79e-05	0.000414	CcSEcCtD
Conivaptan—Skin disorder—Prednisone—asthma	4.74e-05	0.00041	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PDE4A—asthma	4.74e-05	0.000514	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KIF3A—asthma	4.74e-05	0.000514	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—KNG1—asthma	4.73e-05	0.000514	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—BDKRB2—asthma	4.73e-05	0.000513	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AGTR1—asthma	4.71e-05	0.000511	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDE4A—asthma	4.7e-05	0.00051	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KIF3A—asthma	4.7e-05	0.00051	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—KNG1—asthma	4.7e-05	0.00051	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—BDKRB2—asthma	4.69e-05	0.000509	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AGTR1—asthma	4.67e-05	0.000507	CbGpPWpGaD
Conivaptan—Pruritus—Hydrocortisone—asthma	4.64e-05	0.000402	CcSEcCtD
Conivaptan—Feeling abnormal—Dexamethasone—asthma	4.62e-05	0.0004	CcSEcCtD
Conivaptan—Feeling abnormal—Betamethasone—asthma	4.62e-05	0.0004	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL10—asthma	4.6e-05	0.000499	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADCY2—asthma	4.57e-05	0.000496	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL10—asthma	4.57e-05	0.000496	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL3—asthma	4.56e-05	0.000495	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADCY2—asthma	4.54e-05	0.000493	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL3—asthma	4.52e-05	0.000491	CbGpPWpGaD
Conivaptan—Diarrhoea—Hydrocortisone—asthma	4.49e-05	0.000388	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRB2—asthma	4.46e-05	0.000485	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CYSLTR1—asthma	4.44e-05	0.000481	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADRB2—asthma	4.43e-05	0.000481	CbGpPWpGaD
Conivaptan—Body temperature increased—Dexamethasone—asthma	4.43e-05	0.000383	CcSEcCtD
Conivaptan—Body temperature increased—Betamethasone—asthma	4.43e-05	0.000383	CcSEcCtD
Conivaptan—Insomnia—Prednisone—asthma	4.42e-05	0.000382	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—CYSLTR1—asthma	4.4e-05	0.000478	CbGpPWpGaD
Conivaptan—Pruritus—Triamcinolone—asthma	4.37e-05	0.000378	CcSEcCtD
Conivaptan—Pruritus—Methylprednisolone—asthma	4.36e-05	0.000377	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—KNG1—asthma	4.3e-05	0.000467	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—UTS2—asthma	4.28e-05	0.000465	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CMA1—asthma	4.28e-05	0.000465	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—C5AR1—asthma	4.28e-05	0.000465	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL11—asthma	4.28e-05	0.000465	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VIP—asthma	4.28e-05	0.000465	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AGTR1—asthma	4.27e-05	0.000464	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—KNG1—asthma	4.27e-05	0.000463	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CMA1—asthma	4.25e-05	0.000462	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VIP—asthma	4.25e-05	0.000462	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL11—asthma	4.25e-05	0.000462	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—C5AR1—asthma	4.25e-05	0.000462	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—UTS2—asthma	4.25e-05	0.000462	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AGTR1—asthma	4.24e-05	0.000461	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ITPR1—asthma	4.22e-05	0.000458	CbGpPWpGaD
Conivaptan—Diarrhoea—Methylprednisolone—asthma	4.22e-05	0.000365	CcSEcCtD
Conivaptan—Headache—Prednisolone—asthma	4.21e-05	0.000364	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—ITPR1—asthma	4.19e-05	0.000455	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL10—asthma	4.18e-05	0.000453	CbGpPWpGaD
Conivaptan—Constipation—Prednisone—asthma	4.17e-05	0.000361	CcSEcCtD
Conivaptan—Vomiting—Hydrocortisone—asthma	4.17e-05	0.000361	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CXCL10—asthma	4.15e-05	0.00045	CbGpPWpGaD
Conivaptan—Headache—Hydrocortisone—asthma	4.11e-05	0.000356	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCR4—asthma	4.11e-05	0.000446	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR4—asthma	4.08e-05	0.000443	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRB2—asthma	4.05e-05	0.00044	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT6—asthma	4.03e-05	0.000437	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRB2—asthma	4.03e-05	0.000437	CbGpPWpGaD
Conivaptan—Feeling abnormal—Prednisone—asthma	4.02e-05	0.000348	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—STAT6—asthma	4e-05	0.000434	CbGpPWpGaD
Conivaptan—Nausea—Prednisolone—asthma	3.99e-05	0.000345	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—EDN1—asthma	3.99e-05	0.000433	CbGpPWpGaD
Conivaptan—Pruritus—Dexamethasone—asthma	3.97e-05	0.000343	CcSEcCtD
Conivaptan—Pruritus—Betamethasone—asthma	3.97e-05	0.000343	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—EDN1—asthma	3.96e-05	0.00043	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCL5—asthma	3.96e-05	0.00043	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2RB—asthma	3.95e-05	0.000429	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCL5—asthma	3.93e-05	0.000427	CbGpPWpGaD
Conivaptan—Vomiting—Triamcinolone—asthma	3.93e-05	0.00034	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—IL2RB—asthma	3.92e-05	0.000426	CbGpPWpGaD
Conivaptan—Vomiting—Methylprednisolone—asthma	3.92e-05	0.000339	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PDE4D—asthma	3.92e-05	0.000425	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CSF2—asthma	3.9e-05	0.000423	CbGpPWpGaD
Conivaptan—Nausea—Hydrocortisone—asthma	3.9e-05	0.000337	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—PDE4D—asthma	3.89e-05	0.000422	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CSF2—asthma	3.87e-05	0.00042	CbGpPWpGaD
Conivaptan—Headache—Triamcinolone—asthma	3.87e-05	0.000335	CcSEcCtD
Conivaptan—Headache—Methylprednisolone—asthma	3.86e-05	0.000334	CcSEcCtD
Conivaptan—Body temperature increased—Prednisone—asthma	3.86e-05	0.000334	CcSEcCtD
Conivaptan—Diarrhoea—Dexamethasone—asthma	3.84e-05	0.000332	CcSEcCtD
Conivaptan—Diarrhoea—Betamethasone—asthma	3.84e-05	0.000332	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—ITPR1—asthma	3.83e-05	0.000416	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TACR1—asthma	3.82e-05	0.000414	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—C5—asthma	3.82e-05	0.000414	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDE4B—asthma	3.82e-05	0.000414	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CXCL8—asthma	3.82e-05	0.000414	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ITPR1—asthma	3.81e-05	0.000413	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	3.8e-05	0.000413	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDE4B—asthma	3.79e-05	0.000411	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—C5—asthma	3.79e-05	0.000411	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TACR1—asthma	3.79e-05	0.000411	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CXCL8—asthma	3.79e-05	0.000411	CbGpPWpGaD
Conivaptan—Nausea—Triamcinolone—asthma	3.67e-05	0.000318	CcSEcCtD
Conivaptan—Nausea—Methylprednisolone—asthma	3.66e-05	0.000317	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—EDN1—asthma	3.62e-05	0.000393	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EDN1—asthma	3.6e-05	0.00039	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL5—asthma	3.6e-05	0.00039	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PLA2G4A—asthma	3.58e-05	0.000389	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL5—asthma	3.57e-05	0.000387	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CCR5—asthma	3.57e-05	0.000387	CbGpPWpGaD
Conivaptan—Vomiting—Dexamethasone—asthma	3.56e-05	0.000308	CcSEcCtD
Conivaptan—Vomiting—Betamethasone—asthma	3.56e-05	0.000308	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—PLA2G4A—asthma	3.56e-05	0.000386	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CSF2—asthma	3.54e-05	0.000384	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CCR5—asthma	3.54e-05	0.000384	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CSF2—asthma	3.52e-05	0.000382	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL2RA—asthma	3.52e-05	0.000382	CbGpPWpGaD
Conivaptan—Headache—Dexamethasone—asthma	3.51e-05	0.000304	CcSEcCtD
Conivaptan—Headache—Betamethasone—asthma	3.51e-05	0.000304	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CCR3—asthma	3.49e-05	0.000379	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL2RA—asthma	3.49e-05	0.000379	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—C3—asthma	3.49e-05	0.000378	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR3—asthma	3.47e-05	0.000376	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—C3—asthma	3.46e-05	0.000376	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ALB—asthma	3.46e-05	0.000375	CbGpPWpGaD
Conivaptan—Pruritus—Prednisone—asthma	3.45e-05	0.000299	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—NPY—asthma	3.4e-05	0.000369	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPY—asthma	3.38e-05	0.000367	CbGpPWpGaD
Conivaptan—Diarrhoea—Prednisone—asthma	3.34e-05	0.000289	CcSEcCtD
Conivaptan—Nausea—Dexamethasone—asthma	3.33e-05	0.000288	CcSEcCtD
Conivaptan—Nausea—Betamethasone—asthma	3.33e-05	0.000288	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—PPP2CA—asthma	3.3e-05	0.000358	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGTR2—asthma	3.28e-05	0.000356	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PPP2CA—asthma	3.27e-05	0.000355	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGTR2—asthma	3.26e-05	0.000354	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCR5—asthma	3.24e-05	0.000352	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCR5—asthma	3.22e-05	0.000349	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL2RA—asthma	3.19e-05	0.000347	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL2RA—asthma	3.17e-05	0.000344	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—C3—asthma	3.17e-05	0.000344	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDNRB—asthma	3.14e-05	0.000341	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—C3—asthma	3.14e-05	0.000341	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDNRB—asthma	3.12e-05	0.000339	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TAC1—asthma	3.11e-05	0.000338	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPS—asthma	3.11e-05	0.000338	CbGpPWpGaD
Conivaptan—Vomiting—Prednisone—asthma	3.1e-05	0.000269	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—NPS—asthma	3.09e-05	0.000335	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TAC1—asthma	3.09e-05	0.000335	CbGpPWpGaD
Conivaptan—Headache—Prednisone—asthma	3.06e-05	0.000265	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—CXCR3—asthma	3.05e-05	0.000331	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCR3—asthma	3.03e-05	0.000329	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CYBA—asthma	2.96e-05	0.000321	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CYBA—asthma	2.93e-05	0.000319	CbGpPWpGaD
Conivaptan—Nausea—Prednisone—asthma	2.9e-05	0.000251	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—PARP1—asthma	2.89e-05	0.000314	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL5—asthma	2.89e-05	0.000314	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PARP1—asthma	2.87e-05	0.000312	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL5—asthma	2.87e-05	0.000312	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—ALDH2—asthma	2.85e-05	0.000309	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.83e-05	0.000307	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—BDKRB2—asthma	2.79e-05	0.000303	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—POMC—asthma	2.79e-05	0.000303	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—BDKRB2—asthma	2.77e-05	0.000301	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—POMC—asthma	2.77e-05	0.0003	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTT1—asthma	2.71e-05	0.000294	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADCY2—asthma	2.7e-05	0.000293	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL3—asthma	2.69e-05	0.000292	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADCY2—asthma	2.68e-05	0.000291	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL3—asthma	2.67e-05	0.00029	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—KNG1—asthma	2.54e-05	0.000276	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—POMC—asthma	2.53e-05	0.000275	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AGTR1—asthma	2.52e-05	0.000274	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—KNG1—asthma	2.52e-05	0.000274	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—POMC—asthma	2.51e-05	0.000273	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AGTR1—asthma	2.51e-05	0.000272	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CCL2—asthma	2.48e-05	0.000269	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6R—asthma	2.47e-05	0.000268	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL10—asthma	2.47e-05	0.000268	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CCL2—asthma	2.46e-05	0.000267	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—RHOA—asthma	2.46e-05	0.000267	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6R—asthma	2.45e-05	0.000266	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL10—asthma	2.45e-05	0.000266	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—RHOA—asthma	2.44e-05	0.000265	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NTRK1—asthma	2.42e-05	0.000263	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NTRK1—asthma	2.4e-05	0.000261	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB2—asthma	2.4e-05	0.00026	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB2—asthma	2.38e-05	0.000258	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	2.29e-05	0.000249	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ITPR1—asthma	2.27e-05	0.000246	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ITPR1—asthma	2.25e-05	0.000244	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—RHOA—asthma	2.23e-05	0.000242	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—RHOA—asthma	2.21e-05	0.00024	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CD86—asthma	2.16e-05	0.000234	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CXCL8—asthma	2.16e-05	0.000234	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CD86—asthma	2.14e-05	0.000233	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CXCL8—asthma	2.14e-05	0.000232	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDN1—asthma	2.14e-05	0.000232	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDN1—asthma	2.12e-05	0.000231	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL5—asthma	2.12e-05	0.000231	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLA2G4A—asthma	2.12e-05	0.00023	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL5—asthma	2.11e-05	0.000229	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLA2G4A—asthma	2.1e-05	0.000228	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CSF2—asthma	2.09e-05	0.000227	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CSF2—asthma	2.08e-05	0.000225	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—IL2—asthma	2.06e-05	0.000224	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—IL2—asthma	2.05e-05	0.000222	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SMAD3—asthma	2.04e-05	0.000221	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SMAD3—asthma	2.02e-05	0.000219	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CXCL8—asthma	1.96e-05	0.000213	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PPP2CA—asthma	1.95e-05	0.000212	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CXCL8—asthma	1.94e-05	0.000211	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PPP2CA—asthma	1.93e-05	0.00021	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCR5—asthma	1.91e-05	0.000208	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCR5—asthma	1.9e-05	0.000206	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2RA—asthma	1.89e-05	0.000205	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTP1—asthma	1.88e-05	0.000204	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2RA—asthma	1.87e-05	0.000203	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL2—asthma	1.87e-05	0.000203	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—C3—asthma	1.87e-05	0.000203	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL2—asthma	1.86e-05	0.000202	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—C3—asthma	1.86e-05	0.000202	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.85e-05	0.000201	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDGFB—asthma	1.82e-05	0.000198	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDGFB—asthma	1.81e-05	0.000196	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—asthma	1.74e-05	0.000189	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—asthma	1.73e-05	0.000188	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GSTM1—asthma	1.72e-05	0.000187	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.7e-05	0.000185	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FN1—asthma	1.64e-05	0.000178	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FN1—asthma	1.63e-05	0.000177	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—asthma	1.5e-05	0.000162	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—asthma	1.48e-05	0.000161	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CCL2—asthma	1.46e-05	0.000159	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6R—asthma	1.46e-05	0.000158	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CCL2—asthma	1.45e-05	0.000158	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6R—asthma	1.45e-05	0.000157	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EGFR—asthma	1.43e-05	0.000155	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EGFR—asthma	1.42e-05	0.000154	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—asthma	1.37e-05	0.000148	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—asthma	1.36e-05	0.000147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RHOA—asthma	1.32e-05	0.000143	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RHOA—asthma	1.31e-05	0.000142	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOS3—asthma	1.3e-05	0.000142	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOS3—asthma	1.29e-05	0.000141	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—asthma	1.22e-05	0.000132	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CXCL8—asthma	1.16e-05	0.000126	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LTC4S—asthma	1.15e-05	0.000125	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CXCL8—asthma	1.15e-05	0.000125	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL2—asthma	1.11e-05	0.00012	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—asthma	1.1e-05	0.000119	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL2—asthma	1.1e-05	0.000119	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—asthma	1.09e-05	0.000119	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MMP9—asthma	1.05e-05	0.000114	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTEN—asthma	1.04e-05	0.000113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MMP9—asthma	1.04e-05	0.000113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTEN—asthma	1.03e-05	0.000112	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LTA4H—asthma	9.96e-06	0.000108	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—asthma	9.39e-06	0.000102	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—asthma	9.33e-06	0.000101	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—STAT3—asthma	9.3e-06	0.000101	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—STAT3—asthma	9.24e-06	0.0001	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ARG1—asthma	8.71e-06	9.45e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFB1—asthma	8.62e-06	9.36e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFB1—asthma	8.56e-06	9.29e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EGFR—asthma	8.45e-06	9.18e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EGFR—asthma	8.39e-06	9.11e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH7A1—asthma	7.88e-06	8.55e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ARG2—asthma	7.55e-06	8.2e-05	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—asthma	6.5e-06	7.05e-05	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—asthma	6.45e-06	7e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX5AP—asthma	6.26e-06	6.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX15—asthma	6.26e-06	6.79e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CHAT—asthma	5.97e-06	6.48e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALOX5—asthma	5.32e-06	5.78e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CARM1—asthma	5.08e-06	5.51e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—DCN—asthma	5e-06	5.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH2—asthma	4.87e-06	5.28e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTT1—asthma	4.63e-06	5.02e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NQO1—asthma	3.85e-06	4.18e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADCY2—asthma	3.76e-06	4.09e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTP1—asthma	3.21e-06	3.48e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMOX1—asthma	3.16e-06	3.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ITPR1—asthma	3.16e-06	3.43e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CAT—asthma	3.12e-06	3.39e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GSTM1—asthma	2.95e-06	3.2e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PLA2G4A—asthma	2.95e-06	3.2e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPP2CA—asthma	2.72e-06	2.95e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—asthma	2.08e-06	2.26e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALB—asthma	1.9e-06	2.06e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NOS3—asthma	1.82e-06	1.97e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTGS2—asthma	1.66e-06	1.8e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PTEN—asthma	1.45e-06	1.57e-05	CbGpPWpGaD
